Cerebellum’s Eaton ETN Stock Holding History

Cerebellum’s Portfolio ETN Stock Details ETN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$55K	Sell	537 -1,108	-67%	-$108K	0.26%	310
2020 Q2	$130K	Buy	+1,645	New	+$135K	0.09%	112
2019 Q4	$538K	Buy	+5,684	New	+$505K	0.28%	241
2018 Q1	–	Sell	-1,645	Closed	-$130K	–	474
2017 Q4	$130K	Buy	+1,645	New	+$128K	0.09%	112

Other funds holding ETN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Cerebellum's ETN Position: Q3 2020 in Review

Cerebellum reduced its Eaton (ETN) stake by 67% in Q3 2020, selling an estimated $108K and leaving 537 shares worth $55K. The position accounts for 0.26% of the portfolio, ranked #310.

Cerebellum first reported a position in ETN in Q4 2017 and has held it in 4 quarters since. The position peaked at $538K in Q4 2019. 1,108 funds tracked by Wall St. Rank hold ETN as of Q3 2020.

Cerebellum held 537 shares of Eaton worth $55K as of Q3 2020.
Cerebellum sold 1,108 Eaton shares in Q3 2020, an estimated $108K.
Eaton made up 0.26% of Cerebellum's portfolio in Q3 2020, its #310 holding.
Cerebellum first reported a position in Eaton in Q4 2017 and has held it in 4 quarters since.
Cerebellum's Eaton position peaked at $538K in Q4 2019.
1,108 funds tracked by Wall St. Rank held Eaton as of Q3 2020.

Based on Cerebellum's 13F filing for Q3 2020, filed 21 Oct 2020.